A human polyomavirus was recently discovered in Merkel cell carcinoma (MCC) specimens. The Merkel cell polyomavirus (MCPyV) genome undergoes clonal integration into the host cell chromosomes of MCC tumors and expresses small T antigen and truncated large T antigen. Previous studies have consistently reported that MCPyV can be detected in approximately 80% of all MCC tumors. We sought to increase the sensitivity of detection of MCPyV in MCC by developing antibodies capable of detecting large T antigen by immunohistochemistry. In addition, we expanded the repertoire of quantitative PCR primers specific for MCPyV to improve the detection of viral DNA in MCC. Here we report that a novel monoclonal antibody detected MCPyV large T antigen expression in 56 of 58 (97%) unique MCC tumors. PCR analysis specifically detected viral DNA in all 60 unique MCC tumors tested. We also detected inactivating point substitution mutations of TP53 in the two MCC specimens that lacked large T antigen expression and in only 1 of 56 tumors positive for large T antigen. These results indicate that MCPyV is present in MCC tumors more frequently than previously reported and that mutations in TP53 tend to occur in MCC tumors that fail to express MCPyV large T antigen.
Scott J. Rodig, Jingwei Cheng, Jacek Wardzala, Andrew DoRosario, Jessica J. Scanlon, Alvaro C. Laga, Alejandro Martinez-Fernandez, Justine A. Barletta, Andrew M. Bellizzi, Subhashini Sadasivam, Dustin T. Holloway, Dylan J. Cooper, Thomas S. Kupper, Linda C. Wang, James A. DeCaprio
Title and authors | Publication | Year |
---|---|---|
Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation
C Berrios, M Padi, MA Keibler, DE Park, V Molla, J Cheng, SM Lee, G Stephanopoulos, J Quackenbush, JA DeCaprio, RF Kalejta |
PLoS pathogens | 2016 |
RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells
S Hesbacher, L Pfitzer, K Wiedorfer, S Angermeyer, A Borst, S Haferkamp, CJ Scholz, M Wobser, D Schrama, R Houben |
Oncotarget | 2016 |
Merkel cell polyomavirus infection and Merkel cell carcinoma
W Liu, M MacDonald, J You |
Current Opinion in Virology | 2016 |
ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth
S Kleffel, N Lee, C Lezcano, BJ Wilson, K Sobolewski, KR Saab, H Mueller, Q Zhan, C Posch, CP Elco, A DoRosario, SS Garcia, M Thakuria, YE Wang, LC Wang, GF Murphy, MH Frank, T Schatton |
Journal of Investigative Dermatology | 2016 |
Reply to Commentary on “Cytokeratin 20-negative Merkel cell carcinoma is infrequently associated with the Merkel cell polyomavirus”
AG Miner, RM Patel, D Wilson, GW Procop, E Minca, DR Fullen, PW Harms, SD Billings |
Modern Pathology | 2016 |
Merkel Cell Carcinoma Therapeutic Update
NM Cassler, D Merrill, CK Bichakjian, I Brownell |
Current Treatment Options in Oncology | 2016 |
Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection
AS Moshiri, R Doumani, L Yelistratova, A Blom, K Lachance, MM Shinohara, M Delaney, O Chang, S McArdle, H Thomas, MM Asgari, ML Huang, SM Schwartz, P Nghiem |
Journal of Investigative Dermatology | 2016 |
Merkel cell polyomavirus and cutaneous Merkel cell carcinoma
E Minutilli, A Mulè |
Future Science OA | 2016 |
Metastatic Merkel cell carcinoma response to nivolumab
FM Walocko, BY Scheier, PW Harms, LA Fecher, CD Lao |
Journal for ImmunoTherapy of Cancer | 2016 |
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
HL Kaufman, J Russell, O Hamid, S Bhatia, P Terheyden, SP D'Angelo, KC Shih, C Lebbé, GP Linette, M Milella, I Brownell, KD Lewis, JH Lorch, K Chin, L Mahnke, A Heydebreck, JM Cuillerot, P Nghiem |
The Lancet Oncology | 2016 |